GL1X · GenesisL1 explorer

Research workbench

Crystal structure of mouse pyridoxal kinase in apo form

Analyse Crystal structure of mouse pyridoxal kinase in apo form in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6YJZ
Type
protein
Length
1,216 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Pyridoxal kinase
Pockets
16 · best druggability 0.77

Structure

x-ray diffraction · 4 distinct chains · 41% helix, 21% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APyridoxal kinaseprotein30440% helix, 20% strand—
BPyridoxal kinaseprotein30841% helix, 22% strand—
CPyridoxal kinaseprotein30242% helix, 20% strand—
DPyridoxal kinaseprotein30241% helix, 21% strand—

Ligands and binding sites

  • EDO · 1,2-ethanediol · additive · 15 copies · chains A, B, C, D
  • GOL · Glycerol · additive · 5 copies · chains A, B, C, D
  • PG4 · Tetraethylene glycol · additive · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

16 pockets found on a 1 Å grid, 7 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
19550.770.7989EDO
26920.760.8161PG4, EDO
36090.740.8153EDO
4500.710.9916empty
56310.710.7856empty

Interfaces

4 interfaces between chains.

  • A–B · 1926 Ų buried · 27 hydrogen bonds · protein-protein
  • C–D · 1881 Ų buried · 33 hydrogen bonds · protein-protein
  • B–C · 376 Ų buried · 9 hydrogen bonds · protein-protein
  • A–C · 78 Ų buried · 1 hydrogen bond · protein-protein

Compared structures

  • 6YJZ · Crystal structure of mouse pyridoxal kinase in apo form · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.